These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 11396622)

  • 1. Surgical management of dyslipidemia: clinical and experimental evidence.
    Moghadasian MH; Frohlich JJ; Saleem M; Hong JM; Qayumi K; Scudamore CH
    J Invest Surg; 2001; 14(2):71-8. PubMed ID: 11396622
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of partial ileal bypass surgery on mortality and morbidity from coronary heart disease in patients with hypercholesterolemia. Report of the Program on the Surgical Control of the Hyperlipidemias (POSCH).
    Buchwald H; Varco RL; Matts JP; Long JM; Fitch LL; Campbell GS; Pearce MB; Yellin AE; Edmiston WA; Smink RD
    N Engl J Med; 1990 Oct; 323(14):946-55. PubMed ID: 2205799
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lipid results of partial ileal bypass in patients with heterozygous, type II-A hyperlipoproteinemia. Program on the Surgical Control of the Hyperlipidemias.
    Campos CT; Matts JP; Fitch LL; Speech JC; Long JM; Buchwald H
    Surgery; 1990 Oct; 108(4):601-10; discussion 610-1. PubMed ID: 2120785
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Partial ileal bypass surgery in the treatment of heterozygous familial hypercholesterolemia: a review.
    Schouten JA; Beynen AC
    Artery; 1986; 13(4):240-63. PubMed ID: 3518666
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lipoprotein modification achieved by partial ileal bypass: five-year results of The Program on the Surgical Control of the Hyperlipidemias.
    Campos CT; Matts JP; Fitch LL; Speech JC; Long JM; Buchwald H
    Surgery; 1987 Aug; 102(2):424-32. PubMed ID: 3303402
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effective lipid modification by partial ileal bypass reduced long-term coronary heart disease mortality and morbidity: five-year posttrial follow-up report from the POSCH. Program on the Surgical Control of the Hyperlipidemias.
    Buchwald H; Varco RL; Boen JR; Williams SE; Hansen BJ; Campos CT; Campbell GS; Pearce MB; Yellin AE; Edmiston WA; Smink RD; Sawin HS
    Arch Intern Med; 1998 Jun; 158(11):1253-61. PubMed ID: 9625405
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Disease-free intervals after partial ileal bypass in patients with coronary heart disease and hypercholesterolemia: report from the Program on the Surgical Control of the Hyperlipidemias (POSCH).
    Buchwald H; Campos CT; Boen JR; Nguyen PA; Williams SE
    J Am Coll Cardiol; 1995 Aug; 26(2):351-7. PubMed ID: 7608434
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Program on the surgical control of the hyperlipidemias: 1994 report.
    Buchwald H; Campos CT
    J Cardiovasc Pharmacol; 1995; 25 Suppl 4():S3-10. PubMed ID: 8907208
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Program on the Surgical Control of the Hyperlipidemias (POSCH): design and methodology. POSCH Group.
    Buchwald H; Matts JP; Fitch LL; Varco RL; Campbell GS; Pearce M; Yellin A; Smink RD; Sawin HS; Campos CT
    J Clin Epidemiol; 1989; 42(12):1111-27. PubMed ID: 2685177
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Partial ileal bypass for hypercholesterolemia. 20- to 26-year follow-up of the first 57 consecutive cases.
    Buchwald H; Stoller DK; Campos CT; Matts JP; Varco RL
    Ann Surg; 1990 Sep; 212(3):318-29; discussion 329-31. PubMed ID: 2396883
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Women in the POSCH trial. Effects of aggressive cholesterol modification in women with coronary heart disease. The POSCH Group. Program on the Surgical Control of the Hyperlipidemias.
    Buchwald H; Campos CT; Matts JP; Fitch LL; Long JM; Varco RL
    Ann Surg; 1992 Oct; 216(4):389-98; discussion 398-400. PubMed ID: 1417188
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Program on the Surgical Control of the Hyperlipidemias (POSCH): patient entry characteristics. The POSCH Group.
    Matts JP; Buchwald H; Fitch LL; Campos CT; Varco RL; Campbell GS; Pearce MB; Yellin AE; Edmiston WA; Smink RD
    Control Clin Trials; 1991 Apr; 12(2):314-39. PubMed ID: 1645643
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term effects of ileal bypass on lipoproteins in patients with familial hypercholesterolemia.
    Koivisto P; Miettinen TA
    Circulation; 1984 Aug; 70(2):290-6. PubMed ID: 6733883
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of pravastatin on apolipoprotein-specific high density lipoprotein subpopulations and low density lipoprotein subclass phenotypes in patients with primary hypercholesterolemia.
    Cheung MC; Austin MA; Moulin P; Wolf AC; Cryer D; Knopp RH
    Atherosclerosis; 1993 Aug; 102(1):107-19. PubMed ID: 8257447
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Program on the Surgical Control of the Hyperlipidemias: a status report.
    Buchwald H; Moore RB; Matts JP; Long JM; Varco RL; Campbell GS; Pearce MB; Yellin AE; Blankenhorn DH; Holmes WL; Smink RD; Sawin HS
    Surgery; 1982 Oct; 92(4):654-62. PubMed ID: 6750834
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pitavastatin: novel effects on lipid parameters.
    Chapman MJ
    Atheroscler Suppl; 2011 Nov; 12(3):277-84. PubMed ID: 22152282
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term effect of low-density lipoprotein apheresis on plasma lipoproteins and coronary heart disease in native vessels and coronary bypass in severe heterozygous familial hypercholesterolemia.
    Richter WO; Donner MG; Höfling B; Schwandt P
    Metabolism; 1998 Jul; 47(7):863-8. PubMed ID: 9667236
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy and safety of long-term ezetimibe/simvastatin treatment in patients with familial hypercholesterolemia.
    Avellone G; Di Garbo V; Guarnotta V; Scaglione R; Parrinello G; Purpura L; Torres D; Campisi D
    Int Angiol; 2010 Dec; 29(6):514-24. PubMed ID: 21173733
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.